Adult advanced life support: Australian Resuscitation Council Guidelines 2006

EMA - Emergency Medicine Australasia

Volumn 18, Issue 4, 2006, Pages 337-356

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMINOPHYLLINE; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; ATROPINE; BARBITURIC ACID; BICARBONATE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHLORIDE; CORTICOSTEROID; FIBRINOLYTIC AGENT; GLUCONATE CALCIUM; LIDOCAINE; MAGNESIUM CHLORIDE; MAGNESIUM SULFATE; OXYGEN; POTASSIUM CHLORIDE; VASOPRESSIN;

ADULT; AIRWAY OBSTRUCTION; ALGORITHM; ARTIFICIAL VENTILATION; ASYSTOLE; AUSTRALIA; AUTOMATED EXTERNAL DEFIBRILLATOR; BRADYCARDIA; CLINICAL PRACTICE; CLINICAL PROTOCOL; CONSCIOUSNESS DISORDER; CRICOID; DEFIBRILLATION; DELIRIUM; ELECTRODE; EMERGENCY MEDICINE; ENDOTRACHEAL INTUBATION; FACE MASK; FIBRINOLYTIC THERAPY; FIRE; FLUID THERAPY; HEALTH CARE QUALITY; HEART ARREST; HEART BLOCK; HEART PACING; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERKALEMIA; HYPERNATREMIA; HYPERTENSION; HYPERTHERMIA; HYPOTENSION; INDUCED HYPOTHERMIA; INJECTION SITE EXTRAVASATION; INTRAOSSEOUS DRUG ADMINISTRATION; LUNG EMBOLISM; MEDICOLEGAL ASPECT; METABOLIC DISORDER; MUSCLE WEAKNESS; OXYGEN THERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RESCUE PERSONNEL; RESPIRATORY FAILURE; RESUSCITATION; REVIEW; SEIZURE; SLURRED SPEECH; TACHYCARDIA; THROMBOSIS; TISSUE NECROSIS; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

ADULT; ADVANCED CARDIAC LIFE SUPPORT; AIRWAY OBSTRUCTION; AUSTRALIA; CARDIOVASCULAR AGENTS; CLINICAL PROTOCOLS; CRICOID CARTILAGE; DEFIBRILLATORS; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; EMERGENCY MEDICAL SERVICES; HEART ARREST; HEART MASSAGE; HUMANS; HYPOTHERMIA, INDUCED; MONITORING, PHYSIOLOGIC; PRESSURE; REMISSION, SPONTANEOUS; RESPIRATION, ARTIFICIAL; RESPIRATORY ASPIRATION;

EID: 33745583244     PISSN: 17426731     EISSN: 17426723     Source Type: Journal    
DOI: 10.1111/j.1742-6723.2006.00890.x     Document Type: Review

References (68)

1. Kern K. Open-Chest Cardiac Massage. In: Paradis N, Halperin H, Nowak R, eds. Cardiac Arrest. The Science and Practice of Resuscitation Medicine. Baltimore: Williams & Wilkins, 1996; 439-51.
2. Idris A, Florete O, Melker R, Chandra N. Physiology of Ventilation, Oxygenation, and Carbon Dioxide Elimination During Cardiac Arrest. In: Paradis N, Halperin H, Nowak R, eds. Cardiac Arrest. The Science and Practice of Resuscitation Medicine. Baltimore: Williams & Wilkins, 1996; 382-419.
3. Eftestol T, Wik L, Sunde K, Steen PA. Effects of Cardiopulmonary Resuscitation on Predictors of Ventricular Fibrillation Defibrillation Success During Out-of-Hospital Cardiac Arrest. Circulation 2004; 110: 10-15.
4. Becker L. The Epidemiology of Sudden Death. In: Paradis N, Halperin H, Nowak R, eds. Cardiac Arrest. The Science and Practice of Resuscitation Medicine. Baltimore: Williams & Wilkins, 1996; 28-47.
5. Consensus on Science and Treatment Recommendations Part 2: Adult basic life support. Resuscitation 2005; 67(2-3): 187-201.
6. Consensus on Science and Treatment Recommendations Part 3: Defibrillation. Resuscitation 2005; 67(2-3): 203-11.
7. Consensus on Science and Treatment Recommendations Part 4: Advanced life support. Resuscitation 2005; 67(2-3): 213-47.
8. Consensus on Science and Treatment Recommendations Part 8: Interdisciplinary topics. Resuscitation 2005; 67(2-3): 305-14.
9. Pell JP, Sirel JM, Marsden AK, Ford I, Walker NL, Cobbe SM. Presentation, management, and outcome of out of hospital cardiopulmonary arrest: comparison by underlying aetiology. Heart 2003; 89(8): 839-42.
10. Kuisma M, Alaspaa A. Out-of-hospital cardiac arrests of noncardiac origin: epidemiology and outcome. Eur. Heart J. 1997; 18(7): 1122-8.
11. Australian Resuscitation Council. A manual of skills for the use of devices for oxygen administration and/or ventilation of the lungs in emergencies (including competency statements and training guidelines) Harrison GA. editor. Melbourne 1996.
12. Australian Resuscitation Council. A manual of adult Advanced Life Support skills (including competency statements and training guidelines for inclusion in Advanced Life Support courses) Harrison GA. editor. Melbourne 1999.
13. Brimacombe JR, Berry AM. Cricoid pressure Can. J. Anaes. 1997; 44(4): 414-25.
14. Sellick BA. Cricoid pressure to control regurgitation of stomach contents during induction of anaesthesia. Lancet 1961; 2: 404-6.
15. Larsen MP, Eisenberg MS, Cummins RO, Hallstrom AP. Predicting survival from out-of-hospital cardiac arrest: a graphic model. Ann. Emerg. Med. 1993; 22(11): 1652-8.
16. Brown CG, Martin DR, Pepe PE et al. A comparison of standard-dose and high-dose epinephrine in cardiac arrest outside the hospital. The Multicenter High-Dose Epinephrine Study Group. N. Engl. J. Med. 1992; 327(15): 1051-5.
17. Stiell I et al. High dose epinephrine in adult cardiac arrest. N. Engl. J. Med. 1992; 327(15): 1045-50.
18. Weil MH, Tang W. Cardiopulmonary resuscitation: a promise as yet largely unfulfilled. Dis. Mon. 1997; 43(7): 429-501.
19. Vandycke C, Martens P. High dose versus standard dose epinephrine in cardiac arrest - a meta-analysis. Resuscitation 2000; 45(3): 161-6.
20. Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N. Engl. J. Med. 2002; 346: 884-90.
21. Skrifvars MB, Kuisma M, Boyd J, Maatta T, Repo J, Rosenberg PH, Castren M. The use of undiluted amiodarone in the management of out-of-hospital cardiac arrest. Acta. Anaesthesiol. Scand. 2004; 48: 582-7.
22. Petrovic T, Adnet F, Lapandry C. Successful resuscitation of ventricular fibrillation after low-dose amiodarone. Ann. Emerg. Med. 1998; 32: 518-19.
23. Levine JH, Massumi A, Scheinman MM et al. Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group. J. Am. Coll. Cardiol. 1996; 27: 67-75.
24. Somberg JC, Bailin SJ, Haffajee CI et al. Intravenous lidocaine versus intravenous amiodarone (in a new aqueous formulation) for incessant ventricular tachycardia. Am. J. Cardiol. 2002; 90: 853-9.
25. Somberg JC, Timar S, Bailin SJ et al. Lack of a hypotensive effect with rapid administration of a new aqueous formulation of intravenous amiodarone. Am. J. Cardiol. 2004; 93: 576-81.
26. Stiell IG, Wells GA, Field B et al. Advanced cardiac life support in out-of-hospital cardiac arrest. N. Engl. J. Med. 2004; 351: 647-56.
27. Stiell IG, Wells GA, Hebert PC, Laupacis A, Weitzman BN. Association of drug therapy with survival in cardiac arrest: limited role of advanced cardiac life support drugs. Acad. Emerg. Med. 1995; 2: 264-73.
28. Engdahl J, Bang A, Lindqvist J, Herlitz J. Can we define patients with no and those with some chance of survival when found in asystole out of hospital? Am. J. Cardiol. 2000; 86: 610-14.
29. Engdahl J, Bang A, Lindqvist J, Herlitz J. Factors affecting short-and long-term prognosis among 1069 patients with out-of-hospital cardiac arrest and pulseless electrical activity. Resuscitation 2001; 51: 17-25.
30. Dumot JA, Burval DJ, Sprung J et al. Outcome of adult cardiopulmonary resuscitations at a tertiary referral center including results of 'limited' resuscitations. Arch. Intern. Med. 2001; 161: 1751-8.
31. Tortolani AJ, Risucci DA, Powell SR, Dixon R. In-hospital cardiopulmonary resuscitation during asystole. Therapeutic factors associated with 24-hour survival. Chest 1989; 96: 622-6.
32. Cairns C. Ion and Tissue Fluid Changes during Global Ischaemia. In: Paradis N, Halperin H, Nowak R, eds. Cardiac Arrest. The science and practice of resuscitation medicine. Baltimore: Williams & Wilkins, 1996; 73-83.
33. Chamberlain DA. Antiarrhythmic drugs in resuscitation. Heart 1998; 80: 408-11.
34. Aupetit JF, Loufoua-Moundanga J, Faucon G, Timour Q. Ischaemia induced loss or reversal of the effects of the class I antiarrhythmic drugs on vulnerability to fibrillation. British Journal of Pharmacology 1997; 120: 523-9.
35. Tan HL, Kie LI. Prophylactic lidocaine use in acute myocardial infarction revisited in the thrombolytic era (Editorial). American Heart Journal 1999; 137: 770-3.
36. Lindner K, Ahnefeld F, Dirks B, Bowdler I. Comparison of plasma lidocaine levels during cardiopulmonary resuscitation (CPR) after central and peripheral drug administration. Anaesthetist 1989; 38(11): 604-9.
37. Tobey R, Birnbaum G, Allegra J, Horowitz M, Plosay J. Successful Resuscitation and Neurologic Recovery from Refractory Venticular Fibrillation after Magnesium Sulphate Administration. Ann. Emerg. Med. 1992; 21: 92-6.
38. Thel MC, Armstrong AL, McNulty SE, Califf RM, O'Connor CM. Randomised trial of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff. Lancet 1997; 350: 1272-6.
39. Allegra J, Lavery R, Cody R et al. Magnesium sulfate in the treatment of refractory ventricular fibrillation in the prehospital setting. Resuscitation 2001; 49: 245-9.
40. Fatovich D, Prentice D, Dobb G. Magnesium in in-hospital cardiac arrest. Lancet 1998; 351: 446.
41. Hassan TB, Jagger C, Barnett DB. A randomised trial to investigate the efficacy of magnesium sulphate for refractory ventricular fibrillation. Emerg. Med. J. 2002; 19: 57-62.
42. Miller B, Craddock L, Hoffenberg S et al. Pilot study of intravenous magnesium sulfate in refractory cardiac arrest: safety data and recommendations for future studies. Resuscitation 1995; 30: 3-14.
43. Longstreth WT Jr, Fahrenbruch CE, Olsufka M, Walsh TR, Copass MK, Cobb LA. Randomized clinical trial of magnesium, diazepam, or both after out-of-hospital cardiac arrest. Neurology. 2002; 59: 506-14.
44. Baraka A, Ayoub C, Kawkabani N. Magnesium therapy for refractory ventricular fibrillation. J. Cardiothorac. Vasc. Anesth. 2000; 14: 196-9.
45. Dybvik T, Strand T, Steen PA. Buffer therapy during out-of-hospital cardiopulmonary resuscitation. Resuscitation 1995; 29: 89-95.
46. Aufderheide TP, Martin DR, Olson DW et al. Prehospital bicarbonate use in cardiac arrest: a 3-year experience. Am. J. Emerg. Med. 1992; 10: 4-7.
47. Delooz H, Lewi PJ. Are inter-center differences in EMS-management and sodium-bicarbonate administration important for the outcome of CPR? The Cerebral Resuscitation Study Group. Resuscitation 1989; 17 Suppl: S199-206.
48. Roberts D, Landolfo K, Light R, Dobson K. Early predictors of mortality for hospitalized patients suffering cardiopulmonary arrest. Chest 1990; 97: 413-19.
49. Suljaga-Pechtel K, Goldberg E, Strickon P, Berger M, Skovron ML. Cardiopulmonary resuscitation in a hospitalized population: prospective study of factors associated with outcome. Resuscitation 1984; 12: 77-95.
50. Weil MH, Trevino RP, Rackow EC. Sodium bicarbonate during CPR. Does it help or hinder? Chest 1985; 88: 487.
51. Bar-Joseph G, Abramson NS, Kelsey SF, Mashiach T, Craig MT, Safar P. Improved resuscitation outcome in emergency medical systems with increased usage of sodium bicarbonate during cardiopulmonary resuscitation. Acta. Anaesthesiol. Scand. 2005; 49: 6-15.
52. Sandeman DJ, Alahakoon TI, Bentley SC. Tricyclic poisoning-successful management of ventricular fibrillation following massive overdose of imipramine. Anaesth Intensive Care 1997; 25: 542-5.
53. Lindner KH, Dirks B, Strohmenger HU, Prengel AW, Lindner IM, Lurie KG. Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation. Lancet 1997; 349: 535-7.
54. Lindner KH, Prengel AW, Brinkmann A, Strohmenger HU, Lindner IM, Lurie KG. Vasopressin administration in refractory cardiac arrest. Ann. Intern. Med. 1996; 124: 1061-4.
55. Mann K, Berg RA, Nadkarni V. Beneficial effects of vasopressin in prolonged pediatric cardiac arrest: a case series. Resuscitation 2002; 52: 149-56.
56. Morris DC, Dereczyk BE, Grzybowski M, Martin GB, Rivers EP, Wortsman J, Amico JA. Vasopressin can increase coronary perfusion pressure during human cardiopulmonary resuscitation. Acad. Emerg. Med. 1997; 4: 878-83.
57. Stiell IG, Hebert PC, Wells GA et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet. 2001; 358: 105-9.
58. Wenzel V, Krismer AC, Arntz HR, Sitter H, Stadlbauer KH, Lindner KH. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N. Engl. J. Med. 2004; 350: 105-13.
59. Aung K, Htay T. Vasopressin for cardiac arrest: a systematic review and meta-analysis. Arch. Intern. Med. 2005; 165: 17-24.
60. http://www.jficm.anzca.edu.au/publications/policy/icl_2003.htm
61. Minimum standards for transport of critically ill patients. Emerg Med (Fremantle) 2003; 15(2): 197-201.
62. Roberts I, Allsop P, Dickinson M, Curry P, Eastwick-Field P, Eyre G. Airway management training using the laryngeal mask airway: a comparison of two different training programmes. Resuscitation 1997; 33(3): 211-14.
63. Stone BJ, Chantler PJ, Baskett PJ. The incidence of regurgitation during cardiopulmonary resuscitation: a comparison between the bag valve mask and laryngeal mask airway. Resuscitation 1998; 38(1): 3-6.
64. Bernard SA, Gray TW, Buist MD et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N. Engl. J. Med. 2002; 346(8): 557-63.
65. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N. Engl. J. Med. 2002; 346(8): 549-56.
66. Bernard S, Buist M, Monteiro O, Smith K. Induced hypothermia using large volume, ice-cold intravenous fluid in comatose survivors of out-of-hospital cardiac arrest: a preliminary report. Resuscitation 2003; 56(1): 9-13.
67. Tibballs J. Legal liabilities for assistance and lack of assistance rendered by Good Samaritans, volunteers and their organisations. Insurance Law Journal 2005; 16: 254-80.
68. nd edition, Australia, LexisNexus, 2004.